Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple System Atrophy
Conditions
Interventions
ATH434 dose level 1
ATH434 dose level 2
+1 more
Locations
23
United States
University of California San Diego
La Jolla, California, United States
Rush University Medical Center
Chicago, Illinois, United States
Johns Hopkins University
Baltimore, Maryland, United States
Columbia University Irving Medical Center
New York, New York, United States
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
July 1, 2022
Primary Completion Date
November 28, 2024
Completion Date
November 28, 2024
Last Updated
December 13, 2024
NCT04246437
NCT02429557
NCT06098612
NCT04165486
NCT02897063
NCT06848231
Lead Sponsor
Alterity Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions